Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adolescent medicine
advances in neurology
Alzheimer's disease
amyloid angiopathy, cerebral
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, childhood
amyotrophic lateral sclerosis, familial
amyotrophic lateral sclerosis, Parkinson-dementia-complex
amyotrophic lateral sclerosis, post-encephalitic
anticholinergic drugs
apraxia of eyelid opening
athetosis
athetosis, causes of
atlanto axial dislocation, congenital
basal ganglia
basal ganglia, degeneration
benign essential tremor
biologic markers
biopterin deficiency
bradykinesia
brain biopsy
cavernous sinus, syndrome
cerebral palsy
cerebrospinal fluid
cerebrospinal fluid, gamma amino butyric acid
children
chorea
chorea, causes of
cogwheel rigidty
degenerative diseases of CNS
dementia
dementia, frontotemporal
dementia, subcortical
differential diagnosis
dopa responsive dystonia
dopamine
dyskinesia
dyskinesia, causes of
dyskinesia, drug induced
dystonia
dystonia musculorum deformens
dystonia, treatment of
electromyogram
encephalocele
epidemiology of neurology
equinovarus
exercise
exercise-induced neurologic dysfunction
extrapyramidal
familial
fasciculation
Friedreich's ataxia
gait disorder
gamma amino butyric acid
gene mutation
genetic neurologic disorders
genetic testing
Gilles de la Tourette syndrome
hemangioma
hepatolenticular degeneration(Wilson's disease)
homovanillic acid
Huntington's chorea
hydroxyindole acetic acid 5(5HIAA)
hypoxic encephalopathy
imbalance
inclusion bodies, intranuclear
infantile tremor syndrome
Jakob-Creutzfeldt disease
L-dopa
Lewy body disease, diffuse
malformation, CNS, congenital
malformation, vascular
malformation, vascular, cerebral
masked facies
mimics
misdiagnosis
molecular genetics
motor neuron disease
motor neuron disease, juvenile form
movement disorder
movement disorder, extrapyramidal
movement disorder, treatment of
MRI, abnormal
MRI, functional
multiple sclerosis
multiple system atrophy
myoclonus
neurologic disease, diagnoses of
neuronal intranuclear inclusion disease
neurotransmitter
ophthalmoplegia
ophthalmoplegia, painful
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, dystonia with
Parkinson disease, juvenile
Parkinson disease, treatment of
Parkinsonism syndrome
peptides, brain
periodic paralysis
periodic paralysis, thyrotoxic
PRKN gene
procyclidine
progressive neurologic disorder
progressive supranuclear palsy
review article
rigidity
running
serotonin
sinemet
spina bifida
spinal muscular atrophy
spinocerebellar ataxia
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subarachnoid hemorrhage
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
toe walking
Tolosa Hunt syndrome
tonic foot response
torticollis
treatment of neurologic disorder
tremor
tremor, postural
trinucleotide repeats
varicella zoster virus
varicella zoster virus, encephalitis
wheelchair
writers cramp
Showing articles 450 to 500 of 1514 << Previous Next >>

DBS and Diathermy Interaction Induces Severe CNS Damage
Neurol 56:1384-1386, Nutt,J.G.,et al, 2001

Stem-Cell Research: Drawing the Line
Lancet 358:163,217, Greenberg,D.S., 2001

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

Reversible Parkinsonism and MRI Diffusion Abnormalities in Cortical Venous Thrombosis
Neurol 57:364-366, Jenkins,M.,et al, 2001

Effects of Bilateral Subthalamic Nucleus Stimulation on Parkinsonian Gait
Neurol 57:144-146, Stolze,H.,et al, 2001

Effects of Bilateral Subthalamic Stimulation on Cognitive Function in Parkinson Disease
Arch Neurol 58:1223-1227,1205, Alegret,M.,et al, 2001

Deep Brain Stimulation in the Treatment of Parkinson's Disease,A Cost-Effectiveness Analysis
Neurol 57:663-671, Tomaszewski,K.J.&Holloway,R.G., 2001

Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease
NEJM 345:956-963, The Deep-Brain Stimulation for Parkinson's Disease, 2001

Intoxication with Riluzole in Huntington's Diease
Neurol 57:1141-1143, Bodner,Th.,et al, 2001

Improved Accuracy of Clinical Diagnosis of Lewy Body Parkinson's Disease
Neurol 57:1497-1499, Hughes,A.J.,et al, 2001

Daytime Sleepiness and Other Sleep Disorders in Parkinson's Disease
Neurol 57:1392-1396, Ondo,W.G.,et al, 2001

Hallucinations in Parkinson's Disease
Lancet 358:1031-1032, Korczyn,A.D., 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Complete Genomic Screen in Parkinson Disease
JAMA 286:2239-2244, Scott,W.K.,et al, 2001

Complications of Gamma Knife Surgery for Parkinson Disease
Arch Neurol 58:1995-2002,1970, Okun,M.S.,et al, 2001

[123I]Beta-CIT SPECT Imaging Assessment of the Rate of Parkinson's Disease Progression
Neurol 57:2089-2094, Marek,K.,et al, 2001

Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001

Long-Term Follow-Up of Unilateral Pallidotomy in Advanced Parkinson's Disease
NEJM 342:1708-1714, Fine,J.,et al, 2000

Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000

Association Between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
NEJM 342:1560-1567, Lucking,C.B.,et al, 2000

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
JAMA 283:2674-2679, Ross,G.W.,et al, 2000

Depression in Parkinson's Disease
BMJ 320:1287-1288, Allain,H.,et al, 2000

Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000

Quetiapine for L-Dopa-Induced Psychosis in PD
Neurol 54:1538, Weiner,W.J.,et al, 2000

A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000

Structural Changes of the Substantia Nigra in Parkinson's Disease as Revealed by MR Imaging
AJNR 21:697-701, Hutchinson,M.&Raff,U., 2000

Family History and DNA Analysis in Patients With Suspected Huntington's Disease
JNNP 69:54-59, Siesling,S. et al, 2000

Surgery for Parkinson Disease
Arch Neurol 57:1118-1125, Lang,A.E., 2000

Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000

The Brain lesion Responsible for Parkinsonism After Carbon Monoxide Poisnoning
Arch Neurol 57:1214-1218, Sohn,Y.H. et al, 2000

Failure of Long-Term Pallidal Stimulation Corrected by Subthalmaic Stimulation in PD
Neurol 55:728-730, Houeto,J.L. et al, 2000

Olanzapine and Clozapine Comparative Effects on Motor Function in Hallucinating PD Patients
Neurol 55:789-794, 748, Goetz,C.F. et al, 2000

A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents
Pediatrics 106:989-997, Winner,P.,et al, 2000

Computerized Posturography Analysis of Progressive Suprnuclear Palsy
Arch Neurol 57:1464-1469, Ondo,W.,et al, 2000

Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

Predictive Testing for Huntington's Disease: the Calm After the Storm
Lancet 356:1944-1945, Hayden,M.R., 2000

Motor and Cognitive Improvements in Patients with Huntington's Disease after Neurol Trasnplantation
Lancet 356:1975-1979,1945, Bachoud-Levi,A.,et al, 2000

Treatment of Drug-Induced Psychosis with Quetiapine and Clozapine in Parkinson's Disease
Neurol 55:1753-1754, Dewey,R.B.Jr. & O'Suilleabhain,P.E., 2000

Selegiiline and Mortality in Subjects with Parkinson's Disease
Neurol 55:1785-1789,1770, Donnan,P.T.,et al, 2000

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000

Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000

Effects of Bilateral Posteroventral Pallidotomy on Gait of Subjects with Parkinson Disease
Arch Neurol 57:198-204, Siegel,K.L.&Metman,L.V., 2000

Striatal Dopamine Trnasporter Binding Assessed by [I-123]IPT and Single Photon Emission Computed tomography in Patients with Early Parkinson's Disease, Implications for a Preclinical Diagnosis
Arch Neurol 57:205-208, Schwarz,J.,et al, 2000

The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000

Language Disturbances in Corticobasal Degeneration
Neurol 54:990-992, Frattali,C.M.,et al, 2000

The Evolution of Diagnosis in Early Parkinson Disease
ArchNeurol 57:369-372, Jankovic,J.,et al, 2000



Showing articles 450 to 500 of 1514 << Previous Next >>